Neuralink, Elon Musk's brain implant startup, set to begin human trials
Neuralink, Elon Musk's biotechnology startup, is about to embark on its first human clinical trial.
The trial, called the PRIME Study, aims to evaluate the safety and functionality of brain implants for paralysis patients.
The implants will be placed in the part of the brain that controls movement intention.
A chip, installed by a robot, will record and send brain signals to an app.
The initial goal is to enable people to control a computer cursor or keyboard using their thoughts alone.
Individuals with quadriplegia due to spinal cord injury or ALS may qualify for the six-year-long study.
Interested individuals can sign up on Neuralink's website.
Elon Musk has been working on Neuralink's goal of connecting the human brain to a computer for five years.
Inspired by science fiction authors, Musk envisions a "neural lace" technology that can connect all of a person's thoughts to a computer.
While Neuralink has previously tested on animals, the company is now ready to move forward with human trials.
Neuralink faced scrutiny after a monkey died during testing, but the company has addressed safety concerns and obtained FDA clearance for human trials.
The startup also recently raised $280 million in a fundraising round.
With regulatory approval still needed before the implants hit the market, Neuralink is making significant progress in its mission to revolutionize brain-computer interfaces.
Neuralink's upcoming human trials mark a major milestone in the field of brain implants.
With the potential to restore movement and independence for paralysis patients, this groundbreaking technology could change lives.
Stay tuned for updates on Neuralink's progress as they continue to push the boundaries of innovation.
#latestnews #news #cnn
Neuralink, Elon Musk's biotechnology startup, is about to embark on its first human clinical trial.
The trial, called the PRIME Study, aims to evaluate the safety and functionality of brain implants for paralysis patients.
The implants will be placed in the part of the brain that controls movement intention.
A chip, installed by a robot, will record and send brain signals to an app.
The initial goal is to enable people to control a computer cursor or keyboard using their thoughts alone.
Individuals with quadriplegia due to spinal cord injury or ALS may qualify for the six-year-long study.
Interested individuals can sign up on Neuralink's website.
Elon Musk has been working on Neuralink's goal of connecting the human brain to a computer for five years.
Inspired by science fiction authors, Musk envisions a "neural lace" technology that can connect all of a person's thoughts to a computer.
While Neuralink has previously tested on animals, the company is now ready to move forward with human trials.
Neuralink faced scrutiny after a monkey died during testing, but the company has addressed safety concerns and obtained FDA clearance for human trials.
The startup also recently raised $280 million in a fundraising round.
With regulatory approval still needed before the implants hit the market, Neuralink is making significant progress in its mission to revolutionize brain-computer interfaces.
Neuralink's upcoming human trials mark a major milestone in the field of brain implants.
With the potential to restore movement and independence for paralysis patients, this groundbreaking technology could change lives.
Stay tuned for updates on Neuralink's progress as they continue to push the boundaries of innovation.
#latestnews #news #cnn
Category
🗞
NewsTranscript
00:00 Thank you.
00:29 Thank you.
00:36 Thank you.
00:43 Thank you.
00:50 Thank you.
01:00 Thank you.
01:10 Thank you.
01:20 Thank you.
01:30 Thank you.
01:40 Thank you.
01:50 Thank you.
02:00 Thank you.
02:10 Thank you.
02:20 Thank you.
02:30 Thank you.
02:40 Thank you.
02:50 Thank you.
03:00 Thank you.
03:10 Thank you.
03:20 Thank you.
03:30 Thank you.
03:40 Thank you.
03:50 (upbeat music)
03:53 (upbeat music)